DIBUTYLDITHIOCARBAMIC ACID
General Information
Mainterm | DIBUTYLDITHIOCARBAMIC ACID |
CAS Reg.No.(or other ID) | 150-11-8 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 8685 |
IUPAC Name | dibutylcarbamodithioic acid |
InChI | InChI=1S/C9H19NS2/c1-3-5-7-10(9(11)12)8-6-4-2/h3-8H2,1-2H3,(H,11,12) |
InChI Key | SZRLKIKBPASKQH-UHFFFAOYSA-N |
Canonical SMILES | CCCCN(CCCC)C(=S)S |
Molecular Formula | C9H19NS2 |
Wikipedia | dibutyldithiocarbamic acid |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 205.378 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Complexity | 118.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B y A A B g A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A H A Q A A A A A C A D B A A Q C A A M A A A Q E A A A A A A A A A A A A A A g A A A A I A A A A A A A A g A A E A A A A A A C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 36.3 |
Monoisotopic Mass | 205.096 |
Exact Mass | 205.096 |
XLogP3 | None |
XLogP3-AA | 3.4 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 12 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9716 |
Human Intestinal Absorption | HIA+ | 0.9921 |
Caco-2 Permeability | Caco2+ | 0.6394 |
P-glycoprotein Substrate | Non-substrate | 0.6002 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7335 |
Non-inhibitor | 0.9408 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.6340 |
Distribution | ||
Subcellular localization | Lysosome | 0.8536 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8336 |
CYP450 2D6 Substrate | Non-substrate | 0.6860 |
CYP450 3A4 Substrate | Non-substrate | 0.6849 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6480 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.6349 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8543 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.5000 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8177 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6692 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6882 |
Non-inhibitor | 0.7818 | |
AMES Toxicity | Non AMES toxic | 0.8634 |
Carcinogens | Non-carcinogens | 0.6671 |
Fish Toxicity | High FHMT | 0.9814 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9867 |
Honey Bee Toxicity | High HBT | 0.6792 |
Biodegradation | Not ready biodegradable | 0.9443 |
Acute Oral Toxicity | III | 0.6699 |
Carcinogenicity (Three-class) | Non-required | 0.6070 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.7049 | LogS |
Caco-2 Permeability | 1.4997 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.3951 | LD50, mol/kg |
Fish Toxicity | 1.6141 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.4311 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organosulfur compounds |
Class | Not available |
Subclass | Not available |
Intermediate Tree Nodes | Not available |
Direct Parent | Organosulfur compounds |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Organic nitrogen compound - Organopnictogen compound - Hydrocarbon derivative - Organosulfur compound - Organonitrogen compound - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as organosulfur compounds. These are organic compounds containing a carbon-sulfur bond. |
From ClassyFire